serw-MX  [xml]  

 DeCS Categories

C04 Neoplasms .
C04.588 Neoplasms by Site .
C04.588.614 Nervous System Neoplasms .
C04.588.614.550 Paraneoplastic Syndromes, Nervous System .
C04.588.614.550.550 Myelitis, Transverse .
C04.730 Paraneoplastic Syndromes .
C04.730.856 Paraneoplastic Syndromes, Nervous System .
C04.730.856.543 Myelitis, Transverse .
C10 Nervous System Diseases .
C10.114 Autoimmune Diseases of the Nervous System .
C10.114.375 Demyelinating Autoimmune Diseases, CNS .
C10.114.375.600 Myelitis, Transverse .
C10.228 Central Nervous System Diseases .
C10.228.228 Central Nervous System Infections .
C10.228.228.618 Myelitis .
C10.228.228.618.250 Myelitis, Transverse .
C10.228.854 Spinal Cord Diseases .
C10.228.854.525 Myelitis .
C10.228.854.525.553 Myelitis, Transverse .
C10.314 Demyelinating Diseases .
C10.314.350 Demyelinating Autoimmune Diseases, CNS .
C10.314.350.600 Myelitis, Transverse .
C10.574 Neurodegenerative Diseases .
C10.574.781 Paraneoplastic Syndromes, Nervous System .
C10.574.781.625 Myelitis, Transverse .
C20 Immune System Diseases .
C20.111 Autoimmune Diseases .
C20.111.258 Autoimmune Diseases of the Nervous System .
C20.111.258.250 Demyelinating Autoimmune Diseases, CNS .
C20. Myelitis, Transverse .
 Synonyms & Historicals
Myelitis, Transverse .
Myelitis, Acute Transverse .
Myelitis, Necrotizing .
Myelitis, Paraneoplastic .
Myelitis, Postinfectious .
Myelitis, Postvaccinal .
Myelitis, Subacute Transverse .
Postinfectious Myelitis .
Transverse Myelopathy Syndrome .
Acute Transverse Myelitis .
Myelitides, Subacute Transverse .
Myelitis, Demyelinative .
Necrotizing Myelitis .
Paraneoplastic Myelitis .
Postvaccinal Myelitis .
Subacute Transverse Myelitis .
Transverse Myelitis, Acute .
Transverse Myelitis, Subacute .
Transverse Myelopathy Syndromes .
Demyelinative Myelitis .
Transverse Myelitis .
Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6) .
Paraneoplastic Syndromes, Nervous System .
Autonomic Dysfunction, Paraneoplastic .
Nervous System Paraneoplastic Syndromes .
Paraneoplastic Neurologic Syndromes .
Autonomic Dysfunctions, Paraneoplastic .
Encephalomyelitis, Paraneoplastic .
Neurologic Syndrome, Paraneoplastic .
Neurologic Syndromes, Paraneoplastic .
Paraneoplastic Autonomic Dysfunctions .
Paraneoplastic Encephalomyelitides .
Paraneoplastic Neurologic Syndrome .
Syndrome, Paraneoplastic Neurologic .
Syndromes, Paraneoplastic Neurologic .
Paraneoplastic Autonomic Dysfunction .
Paraneoplastic Encephalomyelitis .
Degenerative or inflammatory conditions affecting the central or peripheral nervous system that develop in association with a systemic neoplasm without direct invasion by tumor. They may be associated with circulating antibodies that react with the affected neural tissue. (Intern Med 1996 Dec;35(12):925-9) .
Myelitis .
Infectious Myelitis .
Inflammation, Spinal Cord .
Subacute Necrotising Myelitis .
Inflammations, Spinal Cord .
Inflammatory Myelopathies .
Inflammatory Myelopathy .
Myelitides .
Myelitis, Infectious .
Myelitis, Subacute Necrotising .
Myelopathies, Inflammatory .
Necrotising Myelitis, Subacute .
Spinal Cord Inflammations .
Myelopathy, Inflammatory .
Spinal Cord Inflammation .
Inflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia (see also SPINAL CORD VASCULAR DISEASES). Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction. .
Paraneoplastic Syndromes .
Paraneoplastic Syndrome .
Syndrome, Paraneoplastic .
Syndromes, Paraneoplastic .
In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. .